1 Andreas E,Corinna G,Heinz A,et al.Water channel proteins in the inner ear and their link to hearing impairment and deafness[J].Molecular Aspects of Medicine,2012,33:612.

2 Takeda T,Taguchi D.Aquaporins as potential drug targets for Meniere's disease and its related diseases[J].Handb Exp Pharmacol,2009,190:171.

3 Kitahara T,Maekawa C,Kizawa K,et al.Plasma vasopressin and V2receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops[J].Otology&Neurotology,2009,30:812.

4 Takeda T,Takeda S,Kitano H,et al.Endolymphatic hydrops induced by chronic administration of vasopressin[J].Hear Res,2000,140:1.

5 Mhatre AN,Jero J,Chiappini I,et al.Aquaporin-2expression in the mammalian cochlea and investigation of its role in Meniere's disease[J].Hear Res,2002,170:59.

6 韩红蕾,张连山,顾凤明.正常和膜迷路积水豚鼠内耳水通道蛋白的表达及意义[J].听力学及言语疾病杂志,2010,18:363.

7 Merves M,Bobbitt B,Parker K,et al.Developmental expression of aquaporin 2in the mouse inner ear[J].Laryngoscope,2000,110:1 925.

8 Sawada S,Takeda T,Kitano H,et al.Aquaporin 2regulation by vasopressin in the rat inner ear[J].Neuroreport,2002,13:1 127.

9 Nishioka R,Takeda T,Kakigi A,et al.Expression of aquaporins and vasopressin type 2receptor in the stria vascularis of the cochlea[J].Hear Res,2010,260:11.

10 Nishimura M,Kakiqi A,Takeda T,et al.Time course changes of vasopressin-induced enlargement of the rat intrastrial space and the effects of a vasopressin type 2antagonist[J].Acta Otolaryngol,2009,129:709.

11 Maekawa C,Kitahara T,Kizawa K,et al.Expression and translocation of aquaporin-2in the endolymphatic sac in patients with Meniere’s disease[J].Neuroendocrinol,2010,22:1 157.